iMTA newsletter September 2023

PLEASE READ OUR NEWSLETTER SEPTEMBER 2023 HERE.

In this newsletter:

• Research update on Impact of IHSI for ZIN
  • IHSI aims to achieve the following objectives: 1) promote fair and transparent pharmaceutical prices, 2) use data to drive price reduction, 3) mitigate the impact of disruptive innovation, 4) support effective budgetary policy, and 5) support HTA and regulatory preparation.

• Recently performed work for NICE
  • Upadacitinib for previously treated moderately to severely active Crohn’s disease
  • Difelikefalin for treating pruritus in people having haemodialysis
  • Lumasiran for treating primary hyperoxaluria type 1

Horizon (EU) Projects:

• DEFINITIVE
• IMPORTANT-EU
• NexGen-PH

and much more!

Please read our newsletter HERE.